Cancer. Integrative Oncology

In the comprehensive approach to the oncological patient, the control of systemic inflammation is one of the fundamental pillars. In recent years, science has turned its attention to phytotherapy, highlighting an ancient extract that is showing promising results in recent clinical trials: Boswellia serrata.

In cancer treatment, accurate follow-up is critical to improve treatment outcomes and patient survival. In this sense, tumor markers are a valuable tool in cancer diagnosis and monitoring. They allow us to quantify tumor activity and response to treatment long before performing control imaging tests (CT, PET, CT, MRI).

In the last decade, scientific studies on the use of Chinese herbal formulas for cancer treatment have proliferated. In this article, we will focus on the studies regarding their use in lung cancer.

Honokiol, a bioactive compound derived from the bark of trees of the Magnolia genus, has emerged as a promising therapeutic agent in cancer treatment.

Numerous studies have shown that Sulforaphane exhibits antitumor properties against different types of cancer, including lung, prostate, colon, and breast cancer. In patients under active surveillance for prostate cancer, sulforaphane prolonged the doubling time of prostate-specific antigen (PSA), a marker of tumor progression.

Quercetin is a type of flavonoid compound that comes from nature and is widely found in our diet. Quercetin can exert antitumor effects by altering cell cycle progression, inhibiting cell proliferation, stimulating apoptosis or cell death, inhibiting the progression of angiogenesis or formation of new blood vessels that feed the tumor and metastases.